Hysterectomy may be less expensive for teenagers with Medicare.

Published Date: 08 Mar 2023

Medicare covers people with disabilities who are young enough to get pregnant. Contraception is often not covered for these patients and they opt for hysterectomy or tubal ligation, which may be covered.

Read Full News

Latest News

Kids With Developmental Disabilities Often Face Chronic Pain

Children with developmental disabilities are more likely to have parent-reported chronic pain than those without such conditions.

Pediatric Eating Difficulties Linked to Early Caries

Children with feeding issues often prefer sugary foods, increasing the risk for caries and long-term damage to primary and permanent teeth.

Meningitis Deaths Top 250,000 a Year, Despite Global Decline

Meningitis incidence and mortality rates have declined globally since 1990, but progress toward meeting the 2030 WHO reduction targets is lagging, new research shows.

AI-Based Liver Screening Is Cost-Effective for Fibrosis

AI-based screening with transient elastography is more cost-effective than standard diagnostic approaches in identifying adults at risk for MASLD with advanced fibrosis.

Personality Disorder May Delay Treatment in OCD

Obsessive-compulsive personality disorder is common in obsessive-compulsive disorder (OCD) and is linked to a significant delay in the initiation of OCD treatment, study shows.

Why Sulfur Burps Shouldn’t Be Ignored for GLP-1 Patients

Often unpleasant and unpredictable, these malodorous expressions could mask other side effects.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

Children with developmental disabilities are more likely to have parent-reported chronic pain than those without such conditions.

Children with feeding issues often prefer sugary foods, increasing the risk for caries and long-term damage to primary and permanent teeth.

Meningitis incidence and mortality rates have declined globally since 1990, but progress toward meeting the 2030 WHO reduction targets is lagging, new research shows.

AI-based screening with transient elastography is more cost-effective than standard diagnostic approaches in identifying adults at risk for MASLD with advanced fibrosis.

Obsessive-compulsive personality disorder is common in obsessive-compulsive disorder (OCD) and is linked to a significant delay in the initiation of OCD treatment, study shows.

Often unpleasant and unpredictable, these malodorous expressions could mask other side effects.

News All Time

Conference MDAngle: AAN 2026 Relapsing-Remitting Multiple Sclerosis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in RRMS may affect patient care.

Rethinking GP Training to Meet Australia’s Rising Demand

To confront its GP shortage, Australia is expanding rural training, funding, and new medical school models to rebuild its primary care workforce.

One Quarter of Pregnant Women Have Anemia

Anemia affects more than 1 in 4 pregnant individuals in the US, with prevalence increasing from prenatal care initiation to mid-pregnancy.

Infection Prevention in Europe, Part 3: Building Resilience

Build resilience against infections through everyday routines: standardized discharges, cross-sector antibiotic stewardship, digital records, and regional networks to shorten response times.

To Avoid Clinical Trial Homogeneity, Look to Real-World Data

Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.

GLP-1 Weight Loss Holds Across Race, Age, BMI — but Not Sex

Studies show women lose more weight than men on GLP-1s, but biology may not explain everything.

SCOTUS Conversion Therapy Ruling: What You Should Know

State bans on conversion therapy remain enforceable after the US Supreme Court’s ruling, but experts warn the decision may invite new legal challenges.

Enteritis Linked to Increased Long-Term Risk for IBS

Infectious enteritis is associated with an increased long-term risk of developing irritable bowel syndrome, functional dyspepsia, and elevated healthcare use.

Lab-Grown Esophagus: Hope in Congenital Esophageal Atresia

In a preclinical animal study, implantation of lab-grown esophageal grafts restored swallowing, offering hope for infants with long-gap esophageal atresia.

Simple Kindergarten Tests Flag Early and Late Dyslexia Risk

Screening knowledge of letters, sounds, naming, and word pattern skills at the kindergarten level predicts the risk for dyslexia in grades 1 and 4.

Short IV Methylprednisolone Pulses May Speed GCA Remission

The use of short intravenous pulses of methylprednisolone followed by reduced-dose oral prednisone is associated with a shorter time to remission in patients newly diagnosed with giant cell arteritis.

Are Second-Line Therapies Effective in Ulcerative Colitis?

Infliximab, subcutaneous anti-TNF agents, and ustekinumab show comparable effectiveness as second-line therapies in patients with ulcerative colitis after vedolizumab failure.

IBD: High Mental Health Toll for Newly Diagnosed Patients

Patients newly diagnosed with inflammatory bowel disease report a higher proportion of anxiety and depressive symptoms than the general population.

Antipsychotic Efficacy Plateaus at Lower Doses in Acute SSD

A large meta-analysis reveals that most antipsychotics achieve near-maximal efficacy at the lower end of recommended dose ranges, typically around 3-5 mg/d of risperidone equivalents.

French Nutrition Expert Targeted by Health Deepfakes

Deepfake videos impersonating Serge Hercberg stayed online for days despite multiple reports, exposing gaps in platform moderation and risks to patient trust.

EBV Antibodies May Aid MS Differential Diagnosis

Repeatedly elevated Epstein-Barr virus antibodies on serial blood tests may help distinguish multiple sclerosis from MOGAD and NMOSD, potentially offering a new diagnostic marker.

Recommended News For You

In schizophrenia, sexual dysfunction is frequent.

Some low-grade prostate cancers carry higher risks than biopsy suggests

New protein target discovered for childhood medulloblastomas

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

'Personalized' Approach to RT for Bladder Cancer Promising but Challenging

Adopted cancer cells and the effects of their presence.

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

Recommended Articles For You

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients 

The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects  

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment 

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

2.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

3.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

4.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

5.

Genetics and therapy type determine second cancer risk after childhood treatment, study finds

1.

The Capmist DM: A Revolutionary Way to Combat Dry Mouth

2.

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders

3.

How Prevident is Revolutionizing Oral Care

4.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

5.

Understanding Granulosa Cell Tumors: Symptoms, Diagnosis, and Treatments"

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

2.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

5.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot